Phase 2 Data Strengthened, Strong Cash Position, and Phase 3 Planning Well Advanced −Highlights Phase 2 data for ATH434 in Multiple System ...
ABLi Therapeutics ("ABLi"), a biotechnology company developing therapeutics to address diseases that are associated with activation of Abelson Tyrosine Kinases (c-Abl kinases), announces it has ...
Khaleej Times on MSN
Novartis deepens commitment to the UAE as pharmaceutical market set to double by 2033
The UAE is rapidly consolidating its position as a global pharmaceutical and life sciences hub, with the national market ...
Molecular imaging is redefining in vivo characterization of multiple sclerosis, a demyelinating disease with complex and heterogeneous clinical profiles. Recent advances in PET tracers enable more ...
Extends cash runway into 2028Proceeds expected to enable completion of ProMIS’ landmark Phase 1b AD study and support execution of key clinical ...
Extends cash runway into 2028 Proceeds expected to enable completion of ProMIS' landmark Phase 1b AD study and support execution of key clinical milestones Blinded 6-month top-line data expected ...
Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Jan. /CNW/ — USA News Group News Commentary – Global capital is officially rotating into “Longevity Infrastructure” which is ...
Science-backed adjustments to your stride could be the ultimate weapon against osteoporosis and age-related muscle decline.
Teia Collier on MSN
Unusual behavior during sleep may signal early dementia
Researchers have highlighted a rare sleep condition that impacts around two percent of older adults and might serve as an ...
A collaborative team of researchers and students from Wayne State University's Eugene Applebaum College of Pharmacy and ...
DNA is often described as the instruction manual for building the fundamental components of life. Proteins are helpers that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results